Your trusted health, nutrition, and personalized lifestyle medicine resource

Pioneering Research on SPMs in Rheumatoid Arthritis Therapy


In this interview, Jesmond Dalli, PhD, focuses on effective therapeutic approaches for resolving joint inflammation and regeneration, while highlighting the shortcomings of some existing treatments. He details his latest research on the use of Maresins in treating rheumatoid arthritis patients and the clinical insights gained from this work. Dr. Dalli concludes by explaining how specialized pro-resolving mediators (SPMs) offer a novel approach to therapy and can complement standard pain management treatments.

Jesmond Dalli, PhD, is a Professor of Molecular Pharmacology at the Barts and The London School of Medicine and Dentistry and Queen Mary College.

From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

Sponsored by
© 2024 Metagenics Institute. All Rights Reserved